HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hajime Sano Selected Research

Lipoxygenase Inhibitors

7/20055-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
5/2004Lipoxygenase inhibitors prevent urological cancer cell growth.
11/2003Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hajime Sano Research Topics

Disease

18Neoplasms (Cancer)
02/2008 - 05/2002
17Rheumatoid Arthritis
09/2015 - 02/2004
7Arthritis (Polyarthritis)
01/2015 - 01/2005
6Inflammation
10/2010 - 01/2005
6Renal Cell Carcinoma (Grawitz Tumor)
03/2009 - 12/2003
5Prostatic Neoplasms (Prostate Cancer)
03/2009 - 05/2002
4Graft vs Host Disease (Graft-Versus-Host Disease)
11/2010 - 02/2004
3Testicular Neoplasms (Testicular Cancer)
03/2009 - 09/2002
3Ischemia
07/2008 - 07/2008
3Reperfusion Injury
07/2008 - 02/2002
3Urologic Neoplasms (Urological Cancer)
06/2004 - 12/2003
3Carcinoma (Carcinomatosis)
12/2003 - 05/2003
3Urinary Bladder Neoplasms (Bladder Cancer)
12/2003 - 05/2003
2Bacterial Infections (Bacterial Infection)
01/2011 - 08/2005
2Fibrosis (Cirrhosis)
10/2010 - 01/2006
2Leukemia
09/2004 - 02/2004
2Neoplasm Metastasis (Metastasis)
01/2004 - 11/2003
2Disease Progression
08/2003 - 08/2003
1Hemolysis
01/2015
1HELLP Syndrome
01/2015
1Acute Disease
01/2014
1Gangrene
01/2014
1Eosinophilia
01/2014
1Hematuria
01/2014
1Proteinuria
01/2014
1Vascular Diseases (Vascular Disease)
10/2013
1Connective Tissue Diseases (Connective Tissue Disease)
03/2013
1Systemic Scleroderma (Systemic Sclerosis)
01/2011
1Tuberculosis (Tuberculoses)
01/2011
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2011
1Fever (Fevers)
01/2011
1Tuberculous Peritonitis
01/2011
1Ascites
01/2011
1Lung Injury
10/2010
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2010
1Pulmonary Fibrosis (Hamman Rich Syndrome)
10/2010
1Asthma (Bronchial Asthma)
07/2010
1Hearing Loss (Hearing Impairment)
02/2010
1Cerebral Infarction
02/2010
1Sensorineural Hearing Loss
02/2010
1Otitis Media
01/2010
1Vasculitis (Vasculitides)
01/2010
1Experimental Arthritis
01/2009

Drug/Important Bio-Agent (IBA)

9Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2008 - 01/2003
8Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2015 - 08/2003
7Lipoxygenase (Lipoxygenase-1)IBA
07/2008 - 11/2003
7Arachidonic Acid (Vitamin F)IBA
07/2008 - 11/2003
5EicosanoidsIBA
07/2008 - 11/2003
4sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
06/2012 - 03/2006
4Interleukin-18 (Interleukin 18)IBA
07/2010 - 01/2004
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2009 - 05/2002
4CytokinesIBA
07/2008 - 08/2003
4PPAR gammaIBA
12/2003 - 05/2002
3tocilizumabFDA Link
05/2015 - 01/2014
3CollagenIBA
10/2013 - 01/2005
3leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
03/2009 - 07/2007
3Lipoxygenase InhibitorsIBA
07/2005 - 11/2003
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2005 - 04/2003
2Proto-Oncogene Proteins c-metIBA
01/2015 - 01/2014
2Interleukin-6 (Interleukin 6)IBA
01/2014 - 08/2005
2Lysosphingolipid ReceptorsIBA
06/2012 - 03/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011 - 08/2005
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2010 - 08/2005
2telmisartan (Micardis)FDA Link
03/2009 - 08/2008
2AntigensIBA
05/2008 - 09/2004
2PeptidesIBA
02/2004 - 01/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2004 - 03/2003
2Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
01/2004 - 11/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2003 - 08/2003
2PPAR alphaIBA
05/2003 - 09/2002
1Prostaglandins A (PGA)IBA
09/2015
1EnzymesIBA
01/2015
1HLA-DRB1 antigen (HLA DRB1)IBA
01/2014
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2014
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
03/2013
1Metronidazole (Metric)FDA LinkGeneric
01/2011
1Adenosine DeaminaseIBA
01/2011
1TNFR-Fc fusion protein (etanercept)FDA Link
01/2011
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2011
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2010
1bredinin (mizoribine)IBA
10/2010
1fingolimod (FTY720)FDA Link
08/2010
1Prostaglandins E (PGE)IBA
08/2010
1laminaranIBA
08/2010
1AntibodiesIBA
07/2010
1Staphylococcal Protein A (A, Protein)IBA
07/2010
1Bacterial Proteins (Bacterial Protein)IBA
07/2010
1Interleukin-13IBA
07/2010
1Proteins (Proteins, Gene)IBA
07/2010
1OvalbuminIBA
07/2010
1phenylmethylpyrazoloneIBA
02/2010
1Anti-Bacterial Agents (Antibiotics)IBA
01/2010
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2010
1imatinib (Gleevec)FDA Link
01/2009
1Phosphotransferases (Kinase)IBA
01/2009

Therapy/Procedure

2Transplantation (Transplant Recipients)
01/2014 - 09/2004
2Transplants (Transplant)
09/2004 - 02/2004
1Retreatment
01/2014
1Intravenous Injections
01/2013
1Intraperitoneal Injections
01/2013